109 related articles for article (PubMed ID: 35926682)
1. Biological variation of cardiovascular biochemical markers in patients with Type 2 Diabetes Mellitus.
Wang X; Zeng Y; He H; Zhang M; Li C; Yang L; Chen J; Huang H
Clin Chim Acta; 2022 Sep; 534():161-166. PubMed ID: 35926682
[TBL] [Abstract][Full Text] [Related]
2. Variability of biomarkers in patients with chronic heart failure and healthy controls.
Meijers WC; van der Velde AR; Muller Kobold AC; Dijck-Brouwer J; Wu AH; Jaffe A; de Boer RA
Eur J Heart Fail; 2017 Mar; 19(3):357-365. PubMed ID: 27766733
[TBL] [Abstract][Full Text] [Related]
3. High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study.
Ivandic BT; Spanuth E; Kleber M; Grammer TB; März W
Clin Chem Lab Med; 2011 Jun; 49(6):1053-8. PubMed ID: 21574877
[TBL] [Abstract][Full Text] [Related]
4. Age-Dependent Reference Values for hs-Troponin T and NT-proBNP and Determining Factors in a Cohort of Healthy Children (The LIFE Child Study).
Kiess A; Green J; Willenberg A; Ceglarek U; Dähnert I; Jurkutat A; Körner A; Hiemisch A; Kiess W; Vogel M
Pediatr Cardiol; 2022 Jun; 43(5):1071-1083. PubMed ID: 35277733
[TBL] [Abstract][Full Text] [Related]
5. Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium-glucose co-transporter 2 inhibitor therapy in DECLARE-TIMI 58.
Zelniker TA; Morrow DA; Mosenzon O; Goodrich EL; Jarolim P; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding J; Bode C; Lewis BS; Gause-Nilsson I; Langkilde AM; Fredriksson M; Raz I; Sabatine MS; Wiviott SD
Eur J Heart Fail; 2021 Jun; 23(6):1026-1036. PubMed ID: 33269486
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes.
Jenks SJ; Conway BR; McLachlan S; Teoh WL; Williamson RM; Webb DJ; Welsh P; Sattar N; Strachan MWJ; Price JF
Diabetologia; 2017 Aug; 60(8):1400-1408. PubMed ID: 28528401
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.
Colombo M; Looker HC; Farran B; Agakov F; Brosnan MJ; Welsh P; Sattar N; Livingstone S; Durrington PN; Betteridge DJ; McKeigue PM; Colhoun HM
Atherosclerosis; 2018 Jul; 274():182-190. PubMed ID: 29793175
[TBL] [Abstract][Full Text] [Related]
8. Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial.
Welsh P; Woodward M; Hillis GS; Li Q; Marre M; Williams B; Poulter N; Ryan L; Harrap S; Patel A; Chalmers J; Sattar N
Diabetes Care; 2014 Aug; 37(8):2202-10. PubMed ID: 24879844
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Hyre Anderson A; Yang W; Christenson RH; deFilippi CR; Deo R; Dries DL; Go AS; He J; Kusek JW; Lash JP; Raj D; Rosas S; Wolf M; Zhang X; Shlipak MG; Feldman HI
J Am Soc Nephrol; 2015 Apr; 26(4):946-56. PubMed ID: 25278510
[TBL] [Abstract][Full Text] [Related]
10. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
Scheven L; de Jong PE; Hillege HL; Lambers Heerspink HJ; van Pelt LJ; Kootstra JE; Bakker SJ; Gansevoort RT;
Eur Heart J; 2012 Sep; 33(18):2272-81. PubMed ID: 22740385
[TBL] [Abstract][Full Text] [Related]
11. Utility of bioelectrical phase angle for cardiovascular risk assessment among individuals with and without diabetes mellitus.
Tsilingiris D; Schimpfle L; Κender Z; Sulaj A; von Rauchhaupt E; Herzig S; Szendroedi J; Kopf S
Diab Vasc Dis Res; 2024; 21(1):14791641231223701. PubMed ID: 38305220
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality.
Pavo N; Raderer M; Hülsmann M; Neuhold S; Adlbrecht C; Strunk G; Goliasch G; Gisslinger H; Steger GG; Hejna M; Köstler W; Zöchbauer-Müller S; Marosi C; Kornek G; Auerbach L; Schneider S; Parschalk B; Scheithauer W; Pirker R; Drach J; Zielinski C; Pacher R
Heart; 2015 Dec; 101(23):1874-80. PubMed ID: 26416836
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Prognostic Value of High-Sensitivity Troponin T Added to N-Terminal Pro Brain Natriuretic Peptide Plasma Levels Before Valve Replacement for Severe Aortic Stenosis.
Barbieri F; Senoner T; Adukauskaite A; Dobner S; Holfeld J; Semsroth S; Lambert T; Zweiker D; Theurl T; Rainer PP; Schmidt A; Feuchtner GM; Steinwender C; Hoppe UC; Hintringer F; Bauer A; Müller S; Grimm M; Pfeifer BE; Dichtl W
Am J Cardiol; 2019 Dec; 124(12):1932-1939. PubMed ID: 31699359
[TBL] [Abstract][Full Text] [Related]
14. Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations.
Srivastava PK; Pradhan AD; Cook NR; Ridker PM; Everett BM
Am J Cardiol; 2016 Feb; 117(3):376-81. PubMed ID: 26739393
[TBL] [Abstract][Full Text] [Related]
15. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
[TBL] [Abstract][Full Text] [Related]
16. Week-to-week biological variation of methylmalonic acid and homocysteine in healthy women.
Lindberg M; Borgstrøm Hager H; Brokner M
Scand J Clin Lab Invest; 2019 Jul; 79(4):247-250. PubMed ID: 30957652
[TBL] [Abstract][Full Text] [Related]
17. Pentraxin-3, Troponin T, N-Terminal Pro-B-Type Natriuretic Peptide in Septic Patients.
Vassalli F; Masson S; Meessen J; Pasticci I; Bonifazi M; Vivona L; Caironi P; Busana M; Giosa L; Macrì MM; Romitti F; Novelli D; Quintel M; Latini R; Gattinoni L
Shock; 2020 Nov; 54(5):675-680. PubMed ID: 32941388
[TBL] [Abstract][Full Text] [Related]
18. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
[TBL] [Abstract][Full Text] [Related]
19. Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis.
Welsh P; Tuckwell K; McInnes IB; Sattar N
Atherosclerosis; 2016 Nov; 254():167-171. PubMed ID: 27744141
[TBL] [Abstract][Full Text] [Related]
20. Biological variation of cardiac markers in patients with aortic valve stenosis.
Peeters FECM; Kietselaer BLJH; Hilderink J; van der Linden N; Niens M; Crijns HJGM; Meex SJR
Open Heart; 2019; 6(1):e001040. PubMed ID: 31168392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
